On 29 june 2017 leica biosystems received a complaint that a customer experienced suboptimal tissue processing on their leica asp300.On (b)(6) 2017, a leica field support specialist was notified that as a result of the suboptimal tissue processing, five tissue blocks were undiagnosable.Leica biosystems has made attempts to obtain the patient identifier information but at this time the customer is not able to provide this information.Additionally, to date no confirmation of a rebiopsy has been provided to leica.If additional information is provided a follow up report will be submitted.
|
Following the manufacturer's investigation, the incident was presumably user related due to a wrong application at the customer site.An instrument reagent bottle, used during the tissue processing, was filled with an incorrect reagent before processing, thus affecting the tissue.As per the initial report, the tissue was reported as undiagnosable but no confirmation has been provided that a rebiopsy was necessary or conducted.See manufacturer report number 8010478-2017-00006 for additional information.
|